Orion Oyj ORNBV

HEL: ORNBV | ISIN: FI0009014377 4/07/2025

63,10 EUR (+1,61%)

(+1,61%) 4/07/2025

Grafiek Orion Oyj

Grafiek Orion Oyj

1 dag1d 1,61%
1 week1w 0,00%
1 maand1m 0,24%
3 maanden3m 31,62%
6 maanden6m 41,51%
1 jaar1j 53,19%
5 jaar5j 36,85%

vrijdag 18 juli 2025, 11:00

Kwartaalcijfers (2de kwartaal)

Orion Oyj in het nieuws

Toon enkel gratis nieuws

9 juli 2025 · Inside information: Orion upgrades full-year outlook for 2025 · Persbericht

4 juli 2025 · Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025 · Persbericht

23 juni 2025 · 141,959 Orion Corporation A shares converted into B shares · Persbericht

20 juni 2025 · CHMP recommends third indication for darolutamide for patients with advanced prostate cancer · Persbericht

17 juni 2025 · Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs · Persbericht

3 juni 2025 · U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer · Persbericht

23 mei 2025 · Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market · Persbericht

22 mei 2025 · Orion to host Capital Markets Day today, 22 May 2025, in Helsinki · Persbericht

21 mei 2025 · Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers · Persbericht

8 mei 2025 · Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe